Melanoma & Skin Cancer | Specialty

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

Net Guides: Melanoma

March 13th 2011

Useful Online Resources and Clinical Trials for Melanoma

Crisis Averted? Manufacturers Scurry to Meet Demand for Drugs

March 12th 2011

The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care

Treatment Options for Patients with Stage III & IV Melanoma: Part II: Experimental treatments for stage III/IV or refractory/recurrent melanoma

March 12th 2011

Various immunotherapeutic strategies to treat advanced melanoma have been under investigation for more than a decade

The Emperor of All Maladies: Documenting Cancer's Long Reign

March 12th 2011

The Emperor of All Maladies bills itself as a "biography of cancer," and while author Siddhartha Mukherjee cannot tell us precisely when cancer opened its eyes in this world...

Effects of UV Radiation Are Cumulative

March 9th 2011

An article in Oncogene further explains how ultraviolet (UV) radiation helps transform skin cells into basal cell carcinoma.

Dr. Pearlstone on Technological Challenges

March 8th 2011

John Theurer Cancer Center Opens New Comprehensive Facility

March 4th 2011

The John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey, one of the largest cancer centers in the United States

Oncology Community Facing Severe Drug Shortages

December 19th 2010

Hospitals, pharmacists, and physicians across the United States are reporting shortages of critical anticancer drugs, including carboplatin, cisplatin, dacarbazine, fludarabine, and cytarabine.

ASCO 2010: Novel Therapy First to Extend Survival in Advanced Melanoma

August 14th 2010

In a phase III randomized trial, overall survival (OS) was more than 34% longer for patients with advanced melanoma who received the novel agent ipilimumab

Fast Facts: Skin Cancer and Melanoma

June 25th 2010

A collection of statistics and facts on skin cancer and melanoma

Tremelimumab Is the Focus of Several Studies in Advanced and Metastatic Melanoma

May 25th 2010

Clinical investigations of tremelimumab in melanoma were the focus of several presentations at ASCO.

Findings Implicate Virus as Skin Cancer Cause

May 24th 2010

University of Pittsburgh scientists ecently discovered a virus that they have determined is the cause of Merkel cell carcinoma.